H-Glu(H-Lys-OH)-OH

We are H-Glu(H-Lys-OH)-OH CAS:17105-15-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:H-Glu(H-Lys-OH)-OH
CAS.NO:17105-15-6
Synonyms:H-Glu(H-Lys-OH)-OH
γ-Glu-ε-Lys
6-amino-2-[(4-amino-4-carboxybutanoyl)amino]hexanoic acid
epsilon-(gamma-Glutamyl)-lysine
 
Physical and Chemical Properties:
Density 1.29g/cm3
Boiling Point 610.3ºC at 760mmHg
Molecular Formula C11H21N3O5
Molecular Weight 275.30200
Flash Point 322.9ºC
Vapour Pressure 1.26E-16mmHg at 25°C
Index of Refraction 1.538
 
Specification:
Appearance:White to light yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:εN-(γ-L-Glutamyl)-L-lysine is an γ-glutamylamine that have been shown to contribute to the possibility of neurodegeneration due to the its accumulation in the CSF and affected areas of Huntington Disease brain.

H-Glu(H-Lys-OH)-OH


Related News: The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.38963-94-9 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.4-Hexyl-1,3-benzenediol CAS:136-77-6 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.(1S, 3S, 5S) -tert-butil 3-carbamoil-2-azabiciclo [3.1.0] hexano-2-carboxilato CAS:361440-67-7 China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.

Related Products
Product Name
3-Amino-2-bromo-4-picoline View Details
1,2-Dimercaptobutane View Details
(3R,4S,5R,6R)-2-(dichloromethyl)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol View Details
N-Boc-L-phenylalaninal manufacturer Tetrasodium Glutamate Diacetate Cas:51981-21-6 manufacturer 5-Bromo-2-methylbenzoic acid manufacturer Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate hydrochloride manufacturer Bis(2-butoxyethyl)ether manufacturer